HCTI
Healthcare Triangle, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.79
−7.80%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 25.7M | 13.9M | 11.7M | 33.2M | 45.9M |
| Cost of Revenue | 21.0M | 12.0M | 8.8M | 26.4M | 34.6M |
| Gross Profit | 4.7M | 1.9M | 2.9M | 6.8M | 11.3M |
| Operating Expenses | |||||
| R&D Expense | 473.0K | 536.0K | 429.0K | 799.0K | 8.1M |
| SG&A Expense | 17.6M | 10.4M | 6.2M | 10.4M | 12.2M |
| General & Admin Expense | 13.0M | 7.3M | 4.0M | 5.7M | 5.5M |
| Selling & Marketing Expense | 4.6M | 3.1M | 2.2M | 4.7M | 6.7M |
| Other Expenses | 1.4M | 722.0K | 1.1M | 3.3M | 7.3M |
| Total Operating Expenses | 19.4M | 11.7M | 7.6M | 14.5M | 27.6M |
| Cost and Expenses | 40.4M | 23.7M | 16.4M | 40.9M | 62.2M |
| Operating Income (EBIT) | (14.7M) | (9.8M) | (4.8M) | (7.7M) | (16.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 306.0K | 567.0K | 1.2M | 968.0K | 212.0K |
| Net Interest Income | (306.0K) | (567.0K) | (1.2M) | (968.0K) | (212.0K) |
| Other Non-Op Income/Expense | (2.3M) | 313.0K | (1.2M) | (956.0K) | 2.5M |
| Non-Operating Income (excl Interest) | 2.0M | (880.0K) | (7.0K) | (12.0K) | (2.7M) |
| EBT (Pre-Tax Income) | (17.0M) | (9.5M) | (6.0M) | (8.7M) | (13.9M) |
| Income Tax Expense | 24.0K | — | 12.0K | 35.0K | 506.0K |
| Bottom Line | |||||
| Net Income | (17.0M) | (9.5M) | (6.0M) | (8.7M) | (14.4M) |
| Earnings from Cont. Ops | (17.0M) | (9.5M) | (6.0M) | (8.7M) | (14.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (17.0M) | (9.5M) | (6.0M) | (8.7M) | (14.4M) |
| Per Share | |||||
| Basic EPS | ($65.58) | ($153.16) | ($16,895.00) | ($31,051.00) | ($57,998.00) |
| Diluted EPS | ($65.58) | ($153.16) | ($16,895.00) | ($31,051.00) | ($57,998.00) |
| Revenue Per Share | $9.15 | $224.52 | $33,105.07 | $118,697.34 | $185,352.61 |
| Shares | |||||
| Basic Shares Outstanding | 2.8M | 61871 | 353 | 280 | 248 |
| Diluted Shares Outstanding | 2.8M | 61871 | 353 | 280 | 248 |
| Profitability Metrics | |||||
| EBITDA | (14.7M) | (8.2M) | (3.9M) | (6.1M) | (10.7M) |
| D&A | 2.0M | 705.0K | 889.0K | 1.6M | 2.9M |
| EBIT | (16.7M) | (8.9M) | (4.7M) | (7.7M) | (13.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026